Snibe Snibe (Shenzhen New Industries Biomedical Engineering) is a biomedical company specialized in clinical laboratory instruments and in vitro diagnostic reagents. | Cell IDx Cell IDx is a biotechnology company committed to developing sensitive and specific reagents for research and clinical immunohistochemistry, and other immunoassays. | ![]() Singlera Genomics Singlera Genomics is a provider of liquid biopsy and cancer early detection solutions. | |||
Founding Date | Founding Date 2017 | Founding Date 1995 | Founding Date 1980 | Founding Date 2013 | Founding Date 2014 |
Type | Type Private | Type Public | Type Public | Type Private | Type Subsidiary |
Tags | |||||
Locations | Locations New York, US HQ | Locations Shenzhen, CN HQ | Locations Vancouver, CA HQ | Locations San Diego, US HQ | Locations San Diego, US HQ |
Employees | Employees 903% increase | Employees 2,841 | Employees 1 | Employees 1 | Employees 32 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 7.6 b | Valuation ($) 1.5 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥4.5b (FY, 2024) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods ¥1.3b (FY, 2024) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit ¥3.3b (FY, 2024) | Gross profit $52k (FY, 2021) | Gross profit N/A | Gross profit N/A |
Net income | Net income N/A | Net income ¥1.8b (FY, 2024) | Net income ($1.8m) (FY, 2021) | Net income N/A | Net income N/A |
Snibe (Shenzhen New Industries Biomedical Engineering) is a biomedical company specialized in clinical laboratory instruments and in vitro diagnostic reagents.
View companyCell IDx is a biotechnology company committed to developing sensitive and specific reagents for research and clinical immunohistochemistry, and other immunoassays.
View company
Singlera Genomics is a provider of liquid biopsy and cancer early detection solutions.
View company